AIM ImmunoTech Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer
Prof. Casper H.J. van Eijck, MD, PhD Prof. Casper H.J. van Eijck, MD, PhDData seen to date indicates that Ampligen®...